BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30617453)

  • 1. Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dakhoul L; Jones KR; Gawrieh S; Ghabril M; McShane C; Vuppalanchi R; Vilar-Gomez E; Nephew L; Chalasani N; Lammert C
    Dig Dis Sci; 2019 Jun; 64(6):1705-1710. PubMed ID: 30617453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
    Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
    J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
    Yeoman AD; Al-Chalabi T; Karani JB; Quaglia A; Devlin J; Mieli-Vergani G; Bomford A; O'Grady JG; Harrison PM; Heneghan MA
    Hepatology; 2008 Sep; 48(3):863-70. PubMed ID: 18752332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.
    van Gerven NM; Verwer BJ; Witte BI; van Erpecum KJ; van Buuren HR; Maijers I; Visscher AP; Verschuren EC; van Hoek B; Coenraad MJ; Beuers UH; de Man RA; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Mulder CJ; van Nieuwkerk CM; Bouma G;
    Scand J Gastroenterol; 2014 Oct; 49(10):1245-54. PubMed ID: 25123213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in patients with autoimmune hepatitis.
    Teufel A; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
    World J Gastroenterol; 2009 Feb; 15(5):578-82. PubMed ID: 19195059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.
    Wong RJ; Gish R; Frederick T; Bzowej N; Frenette C
    Dig Dis Sci; 2011 Feb; 56(2):578-85. PubMed ID: 21046244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
    Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
    J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.
    Yan LJ; Yao SY; Meng GX; Liu KX; Li HC; Ding ZN; Dong ZR; Hong JG; Chen ZQ; Li T
    Hepatol Int; 2021 Dec; 15(6):1413-1420. PubMed ID: 34478116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
    Tansel A; Katz LH; El-Serag HB; Thrift AP; Parepally M; Shakhatreh MH; Kanwal F
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1207-1217.e4. PubMed ID: 28215616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
    Braga MH; Cançado GGL; Bittencourt PL; Couto CA; Guedes LV; Lima AMC; Ferraz MLG; Villela-Nogueira CA; Nardelli MJ; Faria LC; Gomes NMF; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; Pace FHL; Pessoa MG; Signorelli IV; Coral GP; Filho JG; Chagas AL; Terrabuio DRB; Cançado ELR;
    Ann Hepatol; 2023; 28(4):101105. PubMed ID: 37088418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.
    Sharma R; Verna EC; Simon TG; Söderling J; Hagström H; Green PHR; Ludvigsson JF
    Am J Epidemiol; 2022 Jan; 191(2):298-319. PubMed ID: 33913487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
    Chang ML; Le PH; Chen WT; Chen TD; Chien RN
    Dig Dis Sci; 2024 Jun; 69(6):2193-2203. PubMed ID: 38653947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patients.
    Danielsson Borssén Å; Almer S; Prytz H; Wallerstedt S; Friis-Liby IL; Bergquist A; Nyhlin N; Hultcrantz R; Sangfelt P; Weiland O; Lindgren S; Verbaan H; Werner M
    Scand J Gastroenterol; 2015 Feb; 50(2):217-23. PubMed ID: 25483724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    Kim BH; Choi HY; Ki M; Kim KA; Jang ES; Jeong SH
    PLoS One; 2017; 12(8):e0182391. PubMed ID: 28771543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis.
    Watanabe T; Soga K; Hirono H; Hasegawa K; Shibasaki K; Kawai H; Aoyagi Y
    World J Gastroenterol; 2009 Jan; 15(2):231-9. PubMed ID: 19132775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study).
    Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Ohta H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Komori A; Ito M; Yatsuhashi H; Nakamura M; Ishibashi H;
    Liver Int; 2012 May; 32(5):837-44. PubMed ID: 22221966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid progression of hepatocellular carcinoma in a patient with autoimmune hepatitis.
    Yamamoto K; Hiura M; Tabaru A; Honma Y; Narita R; Abe S; Shimajiri S; Okamoto K; Yamaguchi K; Harada M
    Intern Med; 2011; 50(13):1409-13. PubMed ID: 21720061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma associated with autoimmune hepatitis.
    Nishiyama R; Kanai T; Abe J; Hara R; Watahiki Y; Sakaguchi T; Nakamura S
    J Hepatobiliary Pancreat Surg; 2004; 11(3):215-9. PubMed ID: 15235898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.